Novartis articles
-
Deciphex partners with Novartis for AI drug research
The collaboration will see the creation and utilisation of an AI suite, to be deployed in pre-clinical pathology assessments. : Deciphex partners with Novartis for AI drug research
-
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results.
-
Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports
Tesla is set to report earnings for its first quarter after the bell on Tuesday, delivering an update on its current and future prospects as...